Document is current
Any future updates will be listed below
-
Authors
Jonuscheit, Marc
Korzekwa, Benedict
Schär, Michael
Mevenkamp, Julian
Wierichs, Stefan
Bobrov, Pavel
Sarabhai, Theresia
Kahl, Sabine
Roden, Michael
Schrauwen-Hinderling, Vera B. https://orcid.org/0000-0001-7795-584X
-
Funding
Funding for this research was provided by:
Bundesministerium für Gesundheit
Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen
Bundesministerium für Bildung und Forschung
German Center for Diabetes Research
HORIZON EUROPE Framework Programme
Deutsche Forschungsgemeinschaft
Schmutzler Stiftung
- License Information
-
More Information
Article History
Received: 22 January 2025
Accepted: 14 April 2025
First Online: 13 May 2025
Declarations
:
: Institutional Review Board approval was obtained. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee (Medical Faculty, Heinrich Heine University, Düsseldorf; ref#4508) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All participants provided written informed consent.
: The authors of this manuscript declare relationships with the following companies. MR received fees consulting, lecturing or serving on advisory boards from Astra Zeneca, Boehringer-Ingelheim, Echosens, Eli Lilly, Madrigal, Merck-MSD, and Novo Nordisk and has performed investigator-initiated research with support from Boehringer-Ingelheim, Novo Nordisk, and Nutricia/Danone to the German Diabetes Center (DDZ). The other authors declare that they have no competing interests.
